Science Explorer Back to mapMap
Discussion
Nonprofit · Greater Sudbury · Canada

Northern Cancer Foundation

ncfsudbury.comROR OpenAlex
Research works
0
fractional, all time
Citations
26
78.8 per fractional work
Top-10% rate
0.0%
all institutions 10.0%
Open access
100%
world 40%
Northern Cancer Foundation

Not ranked overall: Northern Cancer Foundation is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Northern Cancer Foundation work in?

In all years, 67% of research at Northern Cancer Foundation is in Life Sciences, 33% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (67%), Medicine (33%).

Life Sciences: 0 fractional works · 66.7% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 66.7% of its workHealth Sciences: 0 fractional works · 33.3% of its workMedicine: 0 fractional works · 33.3% of its workALL ITS WORKNorthern CancerFoundation0fractional works, all years
Life Sciences67%Health Sciences33%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 2 domains and 2 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology066.7%
    1. Medicine033.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from Northern Cancer Foundation?

The most cited paper from Northern Cancer Foundation is "Polymorphisms inXRCC1,XRCC3, andCCND1and Survival After Treatment for Metastatic Breast Cancer" (Mary A. Bewick, Michael Conlon, Robert M. Lafrenie, 2006), with 78 citations. Next come "The contribution of cytochemistry and immunophenotyping to the reproducibility of the FAB classification in acute leukemia" (3) and "Palliative topical and systemic misonidazole with low-dose irradiation for recurrent carcinoma of the cervix uteri" (1).

Most cited papers
#PaperReleasedCitations
1 Polymorphisms inXRCC1,XRCC3, andCCND1and Survival After Treatment for Metastatic Breast Cancer Mary A. Bewick, Michael Conlon, Robert M. Lafrenie · Journal of Clinical Oncology Open access 21 Nov 2006 78
2 The contribution of cytochemistry and immunophenotyping to the reproducibility of the FAB classification in acute leukemia G Browman, PB Neame, P Soamboonsrup · Blood Open access Oct 1986 3
3 Palliative topical and systemic misonidazole with low-dose irradiation for recurrent carcinoma of the cervix uteri A. E. HAMMOND, Rossall Sealy, Diana Welsh · Cancer Open access Sep 1986 1
All 3 most cited papers, with filters and sorting

Which research topics does Northern Cancer Foundation publish most on?

By volume: DNA Repair Mechanisms, Heat shock proteins research and PARP inhibition in cancer therapy.

DNA Repair Mechanisms0DNA Repair Mechanisms: 0 fractional worksHeat shock proteins rese…0Heat shock proteins research: 0 fractional worksPARP inhibition in cance…0PARP inhibition in cancer therapy: 0 fractional works
Molecular BiologyOncology

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 DNA Repair Mechanisms Molecular Biology 0 works
  2. 2 Heat shock proteins research Molecular Biology 0 works
  3. 3 PARP inhibition in cancer therapy Oncology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available100.0%

World: 40% of research is openly available.

Other research institutions in Greater Sudbury

All research institutions in Greater Sudbury

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Northern Cancer Foundation. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.